课题基金 / 基金详情

Epidemiology of Myelodysplastic Syndromes in Atomic Bomb Survivors

Epidemiology of Myelodysplastic Syndromes in Atomic Bomb Survivors
原子弹爆炸幸存者骨髓增生异常综合征的流行病学
批准号:
17590545
负责人:
IWANAGA Masako
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

IWANAGA Masako的其他基金

相似基金

相关文献

中文摘要
翻译
[背景]骨髓增生异常综合征(MDS)是一种获得性克隆性干细胞疾病,其特征是无效的造血和高进展为白血病的风险。MDS的病因仍不清楚。[目的]探讨辐射暴露与原子弹幸存者发生MDS风险的关系。[方法]回顾收集长崎市5所医院的MDS病例,通过与长崎大学科学数据中心的长崎原子弹幸存者数据库的链接,对长崎原子弹幸存者进行鉴定。通过骨髓涂片镜检和临床资料进行疾病确认。在回溯性队列分析中,我们设定了1980年活着但没有MDS的原子弹幸存者的回溯性队列。在年龄调整的人口分析中,我们利用地级人口的官方统计数据,比较了原子弹幸存者和非原子弹幸存者之间的MDS发病率。[结果]到目前为止,我们积累了1970年代至2004年间确诊的约600例MDS病例,确定了约200例原子弹幸存者。在回溯性队列分析中,在1980年至2004年的87496名幸存者中发现了162例MDS(粗发病率:10.7/103PY)。男性发生MDS的风险高于女性(RR=1.7),距离震中1.5公里以内的幸存者比距震中3.0公里以上的幸存者(RR=4.3)高。在1.5公里内暴露的幸存者中,与RA和RARS亚型相比,RAEB和RAEB-t亚型的风险较高。在年龄调整的人群分析中,原子弹幸存者的MDS粗发病率高于非原子弹幸存者(粗发病率:10.0/106Py比6.49/106Py,RR=1.5)。[讨论]结果表明,辐射暴露与MDS的风险之间存在明显的关联。需要进行辐射剂量分析来证实这种联系。
英文摘要
[Background] Myelodysplastic syndromes (MDS) are acquired clonal stem cell disorders characterized by ineffective hematopoiesis and a high risk of progression to leukemia. Etiologies of MDS are still unknown. So far, there is no large-scale epidemiological study for population exposed to radiation.[Aim] To investigate the association between radiation exposure and a risk of MDS in Atomic bomb survivors.[Methods] Overall MDS cases were retrospectively accumulated from five hospitals in Nagasaki City and then identified Atomic bomb survivors by linkage with the Database of Nagasaki Atomic Bomb Survivors in the Scientific Data Center at Nagasaki University. Disease confirmation was conducted with the microscopic examination of bone marrow smear and clinical data. In retrospective cohort analyses, we set a retrospective cohort of Atomic bomb survivors who were alive at 1980.1.1 but no MDS. In age-adjusted population analyses, we used official prefecture population statistics and then compared MDS incidence between Atomic bomb survivors and Non-Atomic bomb survivors.[Results] Up to now, we accumulated approximately 600 MDS cases diagnosed during 1970' to 2004, and identified around 200 cases who were Atomic bomb survivors. In retrospective cohort analyses, 162 MDS were identified among a cohort of 87496 survivors during 1980 to 2004 (crude incidence rate: 10.7 per 103 PY). Risk of MDS was high in male than female (RR=1.7), in survivors exposed within 1.5km from hypocenter than those over 3.0km (RR=4.3). Risk of subtypes of RAEB & RAEB-t was high compared with subtypes of RA & RARS among survivors exposed within 1.5km. In age-adjusted population analyses, crude incidence rate of MDS was higher in Atomic bomb survivors than Non-Atomic bomb survivors (crude incidence rate: 10.0 vs. 6.49 per 106 PY, RR=1.5).[Discussion] Results suggest a clear association between radiation exposure and a risk of MDS. Radiation dose analysis is needed to confirm this association.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Epidemiology of MDS in Nagasaki City and Nagasaki A-bomb Survivors.
长崎市和长崎原子弹爆炸幸存者 MDS 的流行病学。
DOI: --
发表时间: 2006
期刊: Rinsho Ketsueki 47(9)
影响因子: --
作者: [Iwanaga M, et al.]
通讯作者: et al.
Epidemiology of MDS among Nagasaki Atomic Bomb Survivors.
长崎原子弹爆炸幸存者中 MDS 的流行病学。
DOI: --
发表时间: 2005
期刊: Leukemia Research 29・S1
影响因子: --
作者: [Masako Iwanaga, et al.]
通讯作者: et al.
特集 骨髄異形成症候群(MDS) : 病態の解明と最新の診療 MDS-診断と分類・鑑別すべき病態
专题:骨髓增生异常综合征(MDS):阐明病理学和最新治疗方法 MDS - 待诊断、分类和鉴别的病理状况
DOI: --
发表时间: 2006
期刊: 血液・腫瘍科 53・2
影响因子: --
作者: [Matsuo E, et al., 朝長万左男]
通讯作者: 朝長万左男
MDSの疫学研究 : 長崎市および長崎原爆被爆者集団における発生状況
长崎市及长崎原子弹爆炸幸存者人群MDS的流行病学研究
DOI: --
发表时间: 2006
期刊: 臨床血液 47・9
影响因子: --
作者: [Iwanaga M, et al., 岩永正子 他]
通讯作者: 岩永正子 他
共 19 条
    A new approach to elucidate the risk of malignant lymphoma in atomic bomb survivors
    • 批准号:
      16K15358
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.5万
    • 财政年份:
      2016
    • 负责人:
      IWANAGA Masako
    • 依托单位:
    Research on risk factors for the development of ATL: Long-term cohort study of HTLV-1-infected individuals.
    • 批准号:
      16H05248
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.48万
    • 财政年份:
      2016
    • 负责人:
      IWANAGA Masako
    • 依托单位:
    Risk evaluation based on the clinical characteristics of Hematological malignancies in atomic bomb survivors
    Risk assessment based on the clinical characteristics of leukemia and the related disorders in atomic bomb survivors
    • 批准号:
      20590649
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      IWANAGA Masako
    • 依托单位:
    海外基金